Yilan Huang

703 total citations
40 papers, 505 citations indexed

About

Yilan Huang is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Yilan Huang has authored 40 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Epidemiology and 6 papers in Physiology. Recurrent topics in Yilan Huang's work include Adipose Tissue and Metabolism (4 papers), Diabetes Treatment and Management (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Yilan Huang is often cited by papers focused on Adipose Tissue and Metabolism (4 papers), Diabetes Treatment and Management (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Yilan Huang collaborates with scholars based in China, United States and Thailand. Yilan Huang's co-authors include Xuping Yang, Xiaoyan Zhong, Hongping Shen, Kun Guo, Siwei Wang, Ai‐Wu Ke, Wanlong Zhu, Hu Shan, Fuxiao Liu and Ke Peng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Yilan Huang

36 papers receiving 497 citations

Peers

Yilan Huang
Xiangcheng Zhang China
Kenneth E. Bernstein United States
Luciano Ribeiro Filgueiras Brazil
Yuan Dong China
James Reihill United Kingdom
Paola Simeone Italy
Matheus Ferracini Brazil
Frédéric S. Michel South Africa
Yunfeng Hou China
Xiangcheng Zhang China
Yilan Huang
Citations per year, relative to Yilan Huang Yilan Huang (= 1×) peers Xiangcheng Zhang

Countries citing papers authored by Yilan Huang

Since Specialization
Citations

This map shows the geographic impact of Yilan Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yilan Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yilan Huang more than expected).

Fields of papers citing papers by Yilan Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yilan Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yilan Huang. The network helps show where Yilan Huang may publish in the future.

Co-authorship network of co-authors of Yilan Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Yilan Huang. A scholar is included among the top collaborators of Yilan Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yilan Huang. Yilan Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yingyi, et al.. (2025). Efficient synchronization of high expression and site-specific biotinylation of the PTBP1 RRM3/4 domain. Protein Expression and Purification. 234. 106755–106755.
2.
3.
He, Long, et al.. (2025). Association between GLP-1 RAs and DPP-4 inhibitors with biliary disorders: pharmacovigilance analysis. Frontiers in Pharmacology. 16. 1509561–1509561. 4 indexed citations
4.
Chen, Lei, Qinhui Liu, Xiangyü Li, et al.. (2025). The diabetes medication Canagliflozin attenuates alcoholic liver disease by reducing hepatic lipid accumulation via SIRT1-AMPK-mTORC1 signaling pathway. European Journal of Pharmacology. 992. 177320–177320. 2 indexed citations
5.
He, Long, et al.. (2024). Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events. Frontiers in Pharmacology. 15. 1416985–1416985. 14 indexed citations
6.
Cheng, Hongxia, Yilan Huang, Miaomiao Li, et al.. (2024). HSP90a promotes the resistance to oxaliplatin in HCC through regulating IDH1-induced cell competition. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1871(5). 119680–119680. 1 indexed citations
7.
Guo, Shiwei, Yu Cao, Bowen Cheng, et al.. (2024). A nanoprodrug derived from branched poly (ethylene glycol) recognizes prostate-specific membrane antigen to precisely suppress prostate cancer progression. International Journal of Biological Macromolecules. 282(Pt 2). 136831–136831. 1 indexed citations
8.
Tao, Xuemei, et al.. (2023). Clinical features and risk factors analysis for poor outcomes of severe community-acquired pneumonia in children: a nomogram prediction model. Frontiers in Pediatrics. 11. 1194186–1194186. 2 indexed citations
9.
10.
Zhu, Wanlong, Ke Peng, Yan Zhao, et al.. (2022). Sodium butyrate attenuated diet-induced obesity, insulin resistance and inflammation partly by promoting fat thermogenesis via intro-adipose sympathetic innervation. Frontiers in Pharmacology. 13. 938760–938760. 17 indexed citations
11.
Huang, Yilan, Siwei Wang, Ai‐Wu Ke, & Kun Guo. (2022). Ferroptosis and its interaction with tumor immune microenvironment in liver cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1878(1). 188848–188848. 56 indexed citations
12.
Zhu, Wanlong, Dongmei Tian, Yong Tang, et al.. (2022). Dietary Supplement of Anoectochilus roxburghii (Wall.) Lindl. Polysaccharides Ameliorates Cognitive Dysfunction Induced by High Fat Diet via “Gut-Brain” Axis. Drug Design Development and Therapy. Volume 16. 1931–1945. 12 indexed citations
13.
Liu, Yuanzhi, Yilan Huang, Jingyan Li, et al.. (2022). A comprehensive comparison of medication strategies for platinum-sensitive recurrent ovarian cancer: A Bayesian network meta-analysis. Frontiers in Pharmacology. 13. 1010626–1010626. 5 indexed citations
14.
Cheng, Hongxia, Dongmei Gao, Kangkang Yu, et al.. (2022). Nucleotide sugar transporter SLC35A2 is involved in promoting hepatocellular carcinoma metastasis by regulating cellular glycosylation. Cellular Oncology. 46(2). 283–297. 15 indexed citations
15.
Luo, Li, Rong Wang, Piao Zhang, et al.. (2021). Combining Bioinformatics and Experiments to Identify and Verify Gene Prognostic Markers in Hepatocellular Carcinoma. 1–12. 2 indexed citations
16.
17.
18.
Liu, Xin, et al.. (2020). Efficacy and Safety of Peficitinib for Treating Rheumatoid Arthritis ：A Systematic Review. Zhongguo yaofang. 859–864. 1 indexed citations
19.
Liu, Fuxiao, Yilan Huang, Qianqian Wang, Juan Li, & Hu Shan. (2020). Rescue of Senecavirus A to uncover mutation profiles of its progenies during 80 serial passages in vitro. Veterinary Microbiology. 253. 108969–108969. 24 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangcheng Zhang Breakdown of academic impact, for papers by Kenneth E. Bernstein Breakdown of academic impact, for papers by Luciano Ribeiro Filgueiras Breakdown of academic impact, for papers by Yuan Dong Breakdown of academic impact, for papers by James Reihill Breakdown of academic impact, for papers by Paola Simeone Breakdown of academic impact, for papers by Matheus Ferracini Breakdown of academic impact, for papers by Frédéric S. Michel Breakdown of academic impact, for papers by Yunfeng Hou
Rankless by CCL
2026